Peregrine Pharmaceuticals to Report Fiscal Year 2008 Financial Results

Thursday, July 10, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

TUSTIN, Calif., July 9 PeregrinePharmaceuticals, Inc. (Nasdaq: PPHM) today announced that it will release itsfiscal year 2008 financial results on July 14, 2008 at 7:00 a.m. EDT and willhost a conference call and webcast to discuss the results at 11:30 a.m. EDT onthe same day.

Peregrine's senior management will discuss financial results for thefiscal year ended April 30, 2008 and will review recent operating highlights.A question-and-answer session will follow management's discussion. Allinterested parties are encouraged to listen to the live conference call or thearchived webcast.

The conference call and webcast will begin at 11:30 a.m. EDT/ 8:30 a.m.PDT. To listen to a live broadcast of the call over the Internet or to reviewthe archived webcast, please visit: http://www.peregrineinc.com. The webcastwill be archived on Peregrine's website for 30 days.

To listen to the conference call via telephone, please call the followingnumber approximately 10 minutes prior to the scheduled start time and requestto join the Peregrine Pharmaceuticals call: (800) 860-2442. A telephonicreplay of the conference call will be available starting approximately onehour after the conclusion of the call through July 21, 2008 by calling(877) 344-7529, passcode 382933#.

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with aportfolio of innovative product candidates in clinical trials for thetreatment of cancer and hepatitis C virus (HCV) infection. The company ispursuing three separate clinical programs in cancer and HCV infection with itslead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary AvidBioservices, Inc. (http://www.avidbio.com), which provides development andbio-manufacturing services for both Peregrine and outside customers.Additional information about Peregrine can be found athttp://www.peregrineinc.com.Contacts: GendeLLindheim BioCom Partners Investors Media [email protected] Barbara Lindheim (800) 987-8256 (212) 918-4650

SOURCE Peregrine Pharmaceuticals, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store